BRC News

Researchers can find out more about the practicalities of patient and public involvement (PPI) in biomedical research at a 1-day workshop on 12 July at UCL.

Counting tumour cells in blood samples before and after treatment for advanced neuroendocrine tumours could provide a ‘snapshot’ of how well patients are responding within weeks of starting treatment.

UCLH/UCL clinicians and researchers have been celebrating the first output from the new BRC-funded PET MRI scanner.

BRC research is featured in an extraordinary exhibition of photographs opening this month at University College Hospital (UCH).

Two BRC-supported investigators have been reappointed as NIHR senior investigators in recognition of their status as among the most eminent national researchers.

Professor Anne Schilder from UCL is one of eight of the UK’s most promising leaders in medical health research to be awarded a National Institute for Health Research (NIHR) professorship.

Work by the BRC’s lead for research ethics and governance education Dr Sarah J L Edwards has been cited by President Obama’s commission looking at research standards.

The UCLH/UCL BRC is supporting a summer school of laboratory placements for promising ‘A’ level students from underprivileged backgrounds. The centre is now looking for researchers from UCLH/UCL and students to take part.

The call for the next round of projects under UCL’s Biomedicine Grand Challenge PhD studentship scheme is out.

A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a £20million grant from the Wolfson Foundation, it was announced today.

BRC-supported gene therapy research has offered first proof that adults with haemophilia B benefit from treatment, with therapy reducing the need for injections with clotting factor to prevent bleeds.

Investigators, including BRC-supported researchers, have identified a set of objective, validated measures that can be used to assess new treatments for Huntington’s disease (HD).

UCL and the London School of Hygiene & Tropical Medicine launched the Bloomsbury Institute for Pathogen Research this month.

Engineered viruses such as HIV could hold the key to the future development of vaccines against common intractable infections such as flu, TB and malaria, according to Professor Mary Collins.

Promoting the body’s production of nitric oxide could improve recovery of intensive care patients, according to latest results from an expedition to Mount Everest led by UCL scientists including BRC-funded researchers.